P

Inventor

HILLE THOMAS

DE63 patents
⚠️ This page may combine multiple inventors who share the name “HILLE THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LOHMANN THERAPIE SYST LTS

30 patents
US5240711AAug 31, 1993

Transdermal therapeutic system comprising as active component buprenorphine

LOHMANN THERAPIE SYST LTS169 citations99
US6059913AMay 9, 2000

Method for producing transdermal patches (TTS)

LOHMANN THERAPIE SYST LTS112 citations98
US6814976B1Nov 9, 2004

Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience

LOHMANN THERAPIE SYST LTS44 citations96
US6344211B1Feb 5, 2002

Transdermal absorption of active substances from subcooled melts

LOHMANN THERAPIE SYST LTS69 citations96
US5700480ADec 23, 1997

Transdermal therapeutic system comprising galanthamine as active component

LOHMANN THERAPIE SYST LTS94 citations96
US6264980B1Jul 24, 2001

Transdermal resorption of active substances from supercooled masses of levulic acid

LOHMANN THERAPIE SYST LTS40 citations93
US5939095AAug 17, 1999

Transdermal therapeutic system and a process for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of a poisoning caused by highly toxic organophosphorus neurotoxins in particular soman

LOHMANN THERAPIE SYST LTS20 citations93
US5895660AApr 20, 1999

Deuterated active substances in transdermal application

LOHMANN THERAPIE SYST LTS22 citations93
US7384651B2Jun 10, 2008

Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience

LOHMANN THERAPIE SYST LTS37 citations92
US6194404B1Feb 27, 2001

Process for the isolation of galanthamine

LOHMANN THERAPIE SYST LTS17 citations92
US6187322B1Feb 13, 2001

Process and a device for the production of a flat administration form comprising a preparation which contains pharmaceutical active substances

LOHMANN THERAPIE SYST LTS26 citations92
US5877172AMar 2, 1999

Process for isolating galanthamine

LOHMANN THERAPIE SYST LTS20 citations92
US5391375AFeb 21, 1995

Transdermal therapeutical system with physostigmine as active component and process for the production thereof

LOHMANN THERAPIE SYST LTS35 citations90
US6315854B1Nov 13, 2001

Transdermal therapeutic plaster

LOHMANN THERAPIE SYST LTS21 citations89
US7824707B2Nov 2, 2010

Transdermal therapeutic system provided with improved long-term carrying comfort

LOHMANN THERAPIE SYST LTS10 citations84
US6548510B1Apr 15, 2003

Pharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence

LOHMANN THERAPIE SYST LTS16 citations84
US5891290AApr 6, 1999

Method for the transfer of sections that are self-adhesive on one side from a moving first web onto a moving second web

LOHMANN THERAPIE SYST LTS17 citations83
US6617452B2Sep 9, 2003

Process for the isolation of galanthamine

LOHMANN THERAPIE SYST LTS10 citations81
US6114347ASep 5, 2000

Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors

LOHMANN THERAPIE SYST LTS16 citations81
US6558696B1May 6, 2003

Desoxypeganine

LOHMANN THERAPIE SYST LTS10 citations74
US6599511B1Jul 29, 2003

Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence

LOHMANN THERAPIE SYST LTS8 citations73
US6573376B2Jun 3, 2003

Process for the isolation of galanthamine

LOHMANN THERAPIE SYST LTS7 citations73
US6335328B2Jan 1, 2002

Process for the isolation of galanthamine

LOHMANN THERAPIE SYST LTS7 citations73
US5965155AOct 12, 1999

Transdermal therapeutic system with pentylene tetrazol as active substance

LOHMANN THERAPIE SYST LTS6 citations73
US5681413AOct 28, 1997

Production of transdermal therapeutic systems

LOHMANN THERAPIE SYST LTS15 citations72
US5869086AFeb 9, 1999

Systems for the controlled release of pilocarpine

LOHMANN THERAPIE SYST LTS11 citations71
US6868286B1Mar 15, 2005

Device for a transdermal and phonophoretic combination therapy and the use thereof in a method for medical application

LOHMANN THERAPIE SYST LTS11 citations66
US6627631B1Sep 30, 2003

Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism

LOHMANN THERAPIE SYST LTS3 citations62
US5698216ADec 16, 1997

Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof

LOHMANN THERAPIE SYST LTS2 citations59
US5705186AJan 6, 1998

Pharmaceutical composition for the systemic transdermal administration having the active substance morphine-6-glucuronide

LOHMANN THERAPIE SYST LTS3 citations58

LTS LOHMANN THERAPIE SYSTEME AG

6 patents

HILLE THOMAS

4 patents

UHDE INVENTA FISCHER GMBH

1 patent

INVENTA FISCHER GMBH & CO KG

1 patent

PURDUE PHARMA LP

1 patent

MUELLER WALTER

1 patent

NAT STARCH CHEM INVEST

1 patent

HOFFMANN HANS-RAINER

1 patent

SAP AG

1 patent

BUCHAL TOBIAS

1 patent

LTS LOHMAN THERAPIE SYSTEME AG

1 patent

HYDROPHON KUNSTSTOFFTECHNIK GMBH

1 patent

Showing the top 50 of 63 patents by PatentIndex Score.